Precision Medical Comprehensive Study by Application (Oncology, CNS, Immunology, Respiratory, Other), Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technologies), End-use (Hospitals, Diagnostic Centers, Research & Academic Institutes) Players and Region - Global Market Outlook to 2026

Precision Medical Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Precision Medical Market?

Precision medical is refer as form of medicine which helps for information about a person's own genes or proteins to prevent, diagnose, or treat disease. Precision medicine is understood to be one among the foremost promising approaches for tackling the diseases that have so far eluded effective treatments or cures. many diseases such as cancer, neuro degenerative diseases, and rare genetic conditions take an immense toll on individuals, families, and societies.

The market study is being classified, by Application (Oncology, CNS, Immunology, Respiratory and Other) and major geographies with country level break-up.

Medtronic PLC (Ireland), Pfizer Inc., (United States), Novartis AG (Switzerland), Qiagen (Germany), Teva Pharmaceuticals (Israel), Abbott Laboratories (United States), F. Hoffmann-La Roche AG (Switzerland) and Eli Lilly & Company (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Quest Diagnostics Inc., (United States) and BioMérieux SA (France).

The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Precision Medical market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Precision Medical market by Type, Application and Region.

On the basis of geography, the market of Precision Medical has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rapid growth of genomic analysis
  • Growing prevalence of cancer

Market Trend
  • Advancement in precision medical

Restraints
  • High cost of diagnosis

Opportunities
  • Growing demand for precision medical

Challenges
  • Lack of skilled worker usage of treatment


In 2020, DXRX was launched by Diaceutics PLC. This new technique Diagnostic Network, used for to accelerate the end-to-end development and commercialization of precision medicine diagnostics by reducing time to peak biomarker test adoption for cancer testing from years to months.


Key Target Audience
Provider, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Application
  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Other
By Technology
  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Other Technologies

By End-use
  • Hospitals
  • Diagnostic Centers
  • Research & Academic Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rapid growth of genomic analysis
      • 3.2.2. Growing prevalence of cancer
    • 3.3. Market Challenges
      • 3.3.1. Lack of skilled worker usage of treatment
    • 3.4. Market Trends
      • 3.4.1. Advancement in precision medical
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Precision Medical, by Application, Technology, End-use and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Precision Medical (Value)
      • 5.2.1. Global Precision Medical by: Application (Value)
        • 5.2.1.1. Oncology
        • 5.2.1.2. CNS
        • 5.2.1.3. Immunology
        • 5.2.1.4. Respiratory
        • 5.2.1.5. Other
      • 5.2.2. Global Precision Medical by: Technology (Value)
        • 5.2.2.1. Big Data Analytics
        • 5.2.2.2. Bioinformatics
        • 5.2.2.3. Gene Sequencing
        • 5.2.2.4. Drug Discovery
        • 5.2.2.5. Companion Diagnostics
        • 5.2.2.6. Other Technologies
      • 5.2.3. Global Precision Medical by: End-use (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Diagnostic Centers
        • 5.2.3.3. Research & Academic Institutes
      • 5.2.4. Global Precision Medical Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Precision Medical: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic PLC (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer Inc., (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Novartis AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Qiagen (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Teva Pharmaceuticals (Israel)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Abbott Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Eli Lilly & Company (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Precision Medical Sale, by Application, Technology, End-use and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Precision Medical (Value)
      • 7.2.1. Global Precision Medical by: Application (Value)
        • 7.2.1.1. Oncology
        • 7.2.1.2. CNS
        • 7.2.1.3. Immunology
        • 7.2.1.4. Respiratory
        • 7.2.1.5. Other
      • 7.2.2. Global Precision Medical by: Technology (Value)
        • 7.2.2.1. Big Data Analytics
        • 7.2.2.2. Bioinformatics
        • 7.2.2.3. Gene Sequencing
        • 7.2.2.4. Drug Discovery
        • 7.2.2.5. Companion Diagnostics
        • 7.2.2.6. Other Technologies
      • 7.2.3. Global Precision Medical by: End-use (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Diagnostic Centers
        • 7.2.3.3. Research & Academic Institutes
      • 7.2.4. Global Precision Medical Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Precision Medical: by Application(USD Million)
  • Table 2. Precision Medical Oncology , by Region USD Million (2015-2020)
  • Table 3. Precision Medical CNS , by Region USD Million (2015-2020)
  • Table 4. Precision Medical Immunology , by Region USD Million (2015-2020)
  • Table 5. Precision Medical Respiratory , by Region USD Million (2015-2020)
  • Table 6. Precision Medical Other , by Region USD Million (2015-2020)
  • Table 7. Precision Medical: by Technology(USD Million)
  • Table 8. Precision Medical Big Data Analytics , by Region USD Million (2015-2020)
  • Table 9. Precision Medical Bioinformatics , by Region USD Million (2015-2020)
  • Table 10. Precision Medical Gene Sequencing , by Region USD Million (2015-2020)
  • Table 11. Precision Medical Drug Discovery , by Region USD Million (2015-2020)
  • Table 12. Precision Medical Companion Diagnostics , by Region USD Million (2015-2020)
  • Table 13. Precision Medical Other Technologies , by Region USD Million (2015-2020)
  • Table 14. Precision Medical: by End-use(USD Million)
  • Table 15. Precision Medical Hospitals , by Region USD Million (2015-2020)
  • Table 16. Precision Medical Diagnostic Centers , by Region USD Million (2015-2020)
  • Table 17. Precision Medical Research & Academic Institutes , by Region USD Million (2015-2020)
  • Table 18. South America Precision Medical, by Country USD Million (2015-2020)
  • Table 19. South America Precision Medical, by Application USD Million (2015-2020)
  • Table 20. South America Precision Medical, by Technology USD Million (2015-2020)
  • Table 21. South America Precision Medical, by End-use USD Million (2015-2020)
  • Table 22. Brazil Precision Medical, by Application USD Million (2015-2020)
  • Table 23. Brazil Precision Medical, by Technology USD Million (2015-2020)
  • Table 24. Brazil Precision Medical, by End-use USD Million (2015-2020)
  • Table 25. Argentina Precision Medical, by Application USD Million (2015-2020)
  • Table 26. Argentina Precision Medical, by Technology USD Million (2015-2020)
  • Table 27. Argentina Precision Medical, by End-use USD Million (2015-2020)
  • Table 28. Rest of South America Precision Medical, by Application USD Million (2015-2020)
  • Table 29. Rest of South America Precision Medical, by Technology USD Million (2015-2020)
  • Table 30. Rest of South America Precision Medical, by End-use USD Million (2015-2020)
  • Table 31. Asia Pacific Precision Medical, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific Precision Medical, by Application USD Million (2015-2020)
  • Table 33. Asia Pacific Precision Medical, by Technology USD Million (2015-2020)
  • Table 34. Asia Pacific Precision Medical, by End-use USD Million (2015-2020)
  • Table 35. China Precision Medical, by Application USD Million (2015-2020)
  • Table 36. China Precision Medical, by Technology USD Million (2015-2020)
  • Table 37. China Precision Medical, by End-use USD Million (2015-2020)
  • Table 38. Japan Precision Medical, by Application USD Million (2015-2020)
  • Table 39. Japan Precision Medical, by Technology USD Million (2015-2020)
  • Table 40. Japan Precision Medical, by End-use USD Million (2015-2020)
  • Table 41. India Precision Medical, by Application USD Million (2015-2020)
  • Table 42. India Precision Medical, by Technology USD Million (2015-2020)
  • Table 43. India Precision Medical, by End-use USD Million (2015-2020)
  • Table 44. South Korea Precision Medical, by Application USD Million (2015-2020)
  • Table 45. South Korea Precision Medical, by Technology USD Million (2015-2020)
  • Table 46. South Korea Precision Medical, by End-use USD Million (2015-2020)
  • Table 47. Taiwan Precision Medical, by Application USD Million (2015-2020)
  • Table 48. Taiwan Precision Medical, by Technology USD Million (2015-2020)
  • Table 49. Taiwan Precision Medical, by End-use USD Million (2015-2020)
  • Table 50. Australia Precision Medical, by Application USD Million (2015-2020)
  • Table 51. Australia Precision Medical, by Technology USD Million (2015-2020)
  • Table 52. Australia Precision Medical, by End-use USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Precision Medical, by Application USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Precision Medical, by Technology USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Precision Medical, by End-use USD Million (2015-2020)
  • Table 56. Europe Precision Medical, by Country USD Million (2015-2020)
  • Table 57. Europe Precision Medical, by Application USD Million (2015-2020)
  • Table 58. Europe Precision Medical, by Technology USD Million (2015-2020)
  • Table 59. Europe Precision Medical, by End-use USD Million (2015-2020)
  • Table 60. Germany Precision Medical, by Application USD Million (2015-2020)
  • Table 61. Germany Precision Medical, by Technology USD Million (2015-2020)
  • Table 62. Germany Precision Medical, by End-use USD Million (2015-2020)
  • Table 63. France Precision Medical, by Application USD Million (2015-2020)
  • Table 64. France Precision Medical, by Technology USD Million (2015-2020)
  • Table 65. France Precision Medical, by End-use USD Million (2015-2020)
  • Table 66. Italy Precision Medical, by Application USD Million (2015-2020)
  • Table 67. Italy Precision Medical, by Technology USD Million (2015-2020)
  • Table 68. Italy Precision Medical, by End-use USD Million (2015-2020)
  • Table 69. United Kingdom Precision Medical, by Application USD Million (2015-2020)
  • Table 70. United Kingdom Precision Medical, by Technology USD Million (2015-2020)
  • Table 71. United Kingdom Precision Medical, by End-use USD Million (2015-2020)
  • Table 72. Netherlands Precision Medical, by Application USD Million (2015-2020)
  • Table 73. Netherlands Precision Medical, by Technology USD Million (2015-2020)
  • Table 74. Netherlands Precision Medical, by End-use USD Million (2015-2020)
  • Table 75. Rest of Europe Precision Medical, by Application USD Million (2015-2020)
  • Table 76. Rest of Europe Precision Medical, by Technology USD Million (2015-2020)
  • Table 77. Rest of Europe Precision Medical, by End-use USD Million (2015-2020)
  • Table 78. MEA Precision Medical, by Country USD Million (2015-2020)
  • Table 79. MEA Precision Medical, by Application USD Million (2015-2020)
  • Table 80. MEA Precision Medical, by Technology USD Million (2015-2020)
  • Table 81. MEA Precision Medical, by End-use USD Million (2015-2020)
  • Table 82. Middle East Precision Medical, by Application USD Million (2015-2020)
  • Table 83. Middle East Precision Medical, by Technology USD Million (2015-2020)
  • Table 84. Middle East Precision Medical, by End-use USD Million (2015-2020)
  • Table 85. Africa Precision Medical, by Application USD Million (2015-2020)
  • Table 86. Africa Precision Medical, by Technology USD Million (2015-2020)
  • Table 87. Africa Precision Medical, by End-use USD Million (2015-2020)
  • Table 88. North America Precision Medical, by Country USD Million (2015-2020)
  • Table 89. North America Precision Medical, by Application USD Million (2015-2020)
  • Table 90. North America Precision Medical, by Technology USD Million (2015-2020)
  • Table 91. North America Precision Medical, by End-use USD Million (2015-2020)
  • Table 92. United States Precision Medical, by Application USD Million (2015-2020)
  • Table 93. United States Precision Medical, by Technology USD Million (2015-2020)
  • Table 94. United States Precision Medical, by End-use USD Million (2015-2020)
  • Table 95. Canada Precision Medical, by Application USD Million (2015-2020)
  • Table 96. Canada Precision Medical, by Technology USD Million (2015-2020)
  • Table 97. Canada Precision Medical, by End-use USD Million (2015-2020)
  • Table 98. Mexico Precision Medical, by Application USD Million (2015-2020)
  • Table 99. Mexico Precision Medical, by Technology USD Million (2015-2020)
  • Table 100. Mexico Precision Medical, by End-use USD Million (2015-2020)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Precision Medical: by Application(USD Million)
  • Table 110. Precision Medical Oncology , by Region USD Million (2021-2026)
  • Table 111. Precision Medical CNS , by Region USD Million (2021-2026)
  • Table 112. Precision Medical Immunology , by Region USD Million (2021-2026)
  • Table 113. Precision Medical Respiratory , by Region USD Million (2021-2026)
  • Table 114. Precision Medical Other , by Region USD Million (2021-2026)
  • Table 115. Precision Medical: by Technology(USD Million)
  • Table 116. Precision Medical Big Data Analytics , by Region USD Million (2021-2026)
  • Table 117. Precision Medical Bioinformatics , by Region USD Million (2021-2026)
  • Table 118. Precision Medical Gene Sequencing , by Region USD Million (2021-2026)
  • Table 119. Precision Medical Drug Discovery , by Region USD Million (2021-2026)
  • Table 120. Precision Medical Companion Diagnostics , by Region USD Million (2021-2026)
  • Table 121. Precision Medical Other Technologies , by Region USD Million (2021-2026)
  • Table 122. Precision Medical: by End-use(USD Million)
  • Table 123. Precision Medical Hospitals , by Region USD Million (2021-2026)
  • Table 124. Precision Medical Diagnostic Centers , by Region USD Million (2021-2026)
  • Table 125. Precision Medical Research & Academic Institutes , by Region USD Million (2021-2026)
  • Table 126. South America Precision Medical, by Country USD Million (2021-2026)
  • Table 127. South America Precision Medical, by Application USD Million (2021-2026)
  • Table 128. South America Precision Medical, by Technology USD Million (2021-2026)
  • Table 129. South America Precision Medical, by End-use USD Million (2021-2026)
  • Table 130. Brazil Precision Medical, by Application USD Million (2021-2026)
  • Table 131. Brazil Precision Medical, by Technology USD Million (2021-2026)
  • Table 132. Brazil Precision Medical, by End-use USD Million (2021-2026)
  • Table 133. Argentina Precision Medical, by Application USD Million (2021-2026)
  • Table 134. Argentina Precision Medical, by Technology USD Million (2021-2026)
  • Table 135. Argentina Precision Medical, by End-use USD Million (2021-2026)
  • Table 136. Rest of South America Precision Medical, by Application USD Million (2021-2026)
  • Table 137. Rest of South America Precision Medical, by Technology USD Million (2021-2026)
  • Table 138. Rest of South America Precision Medical, by End-use USD Million (2021-2026)
  • Table 139. Asia Pacific Precision Medical, by Country USD Million (2021-2026)
  • Table 140. Asia Pacific Precision Medical, by Application USD Million (2021-2026)
  • Table 141. Asia Pacific Precision Medical, by Technology USD Million (2021-2026)
  • Table 142. Asia Pacific Precision Medical, by End-use USD Million (2021-2026)
  • Table 143. China Precision Medical, by Application USD Million (2021-2026)
  • Table 144. China Precision Medical, by Technology USD Million (2021-2026)
  • Table 145. China Precision Medical, by End-use USD Million (2021-2026)
  • Table 146. Japan Precision Medical, by Application USD Million (2021-2026)
  • Table 147. Japan Precision Medical, by Technology USD Million (2021-2026)
  • Table 148. Japan Precision Medical, by End-use USD Million (2021-2026)
  • Table 149. India Precision Medical, by Application USD Million (2021-2026)
  • Table 150. India Precision Medical, by Technology USD Million (2021-2026)
  • Table 151. India Precision Medical, by End-use USD Million (2021-2026)
  • Table 152. South Korea Precision Medical, by Application USD Million (2021-2026)
  • Table 153. South Korea Precision Medical, by Technology USD Million (2021-2026)
  • Table 154. South Korea Precision Medical, by End-use USD Million (2021-2026)
  • Table 155. Taiwan Precision Medical, by Application USD Million (2021-2026)
  • Table 156. Taiwan Precision Medical, by Technology USD Million (2021-2026)
  • Table 157. Taiwan Precision Medical, by End-use USD Million (2021-2026)
  • Table 158. Australia Precision Medical, by Application USD Million (2021-2026)
  • Table 159. Australia Precision Medical, by Technology USD Million (2021-2026)
  • Table 160. Australia Precision Medical, by End-use USD Million (2021-2026)
  • Table 161. Rest of Asia-Pacific Precision Medical, by Application USD Million (2021-2026)
  • Table 162. Rest of Asia-Pacific Precision Medical, by Technology USD Million (2021-2026)
  • Table 163. Rest of Asia-Pacific Precision Medical, by End-use USD Million (2021-2026)
  • Table 164. Europe Precision Medical, by Country USD Million (2021-2026)
  • Table 165. Europe Precision Medical, by Application USD Million (2021-2026)
  • Table 166. Europe Precision Medical, by Technology USD Million (2021-2026)
  • Table 167. Europe Precision Medical, by End-use USD Million (2021-2026)
  • Table 168. Germany Precision Medical, by Application USD Million (2021-2026)
  • Table 169. Germany Precision Medical, by Technology USD Million (2021-2026)
  • Table 170. Germany Precision Medical, by End-use USD Million (2021-2026)
  • Table 171. France Precision Medical, by Application USD Million (2021-2026)
  • Table 172. France Precision Medical, by Technology USD Million (2021-2026)
  • Table 173. France Precision Medical, by End-use USD Million (2021-2026)
  • Table 174. Italy Precision Medical, by Application USD Million (2021-2026)
  • Table 175. Italy Precision Medical, by Technology USD Million (2021-2026)
  • Table 176. Italy Precision Medical, by End-use USD Million (2021-2026)
  • Table 177. United Kingdom Precision Medical, by Application USD Million (2021-2026)
  • Table 178. United Kingdom Precision Medical, by Technology USD Million (2021-2026)
  • Table 179. United Kingdom Precision Medical, by End-use USD Million (2021-2026)
  • Table 180. Netherlands Precision Medical, by Application USD Million (2021-2026)
  • Table 181. Netherlands Precision Medical, by Technology USD Million (2021-2026)
  • Table 182. Netherlands Precision Medical, by End-use USD Million (2021-2026)
  • Table 183. Rest of Europe Precision Medical, by Application USD Million (2021-2026)
  • Table 184. Rest of Europe Precision Medical, by Technology USD Million (2021-2026)
  • Table 185. Rest of Europe Precision Medical, by End-use USD Million (2021-2026)
  • Table 186. MEA Precision Medical, by Country USD Million (2021-2026)
  • Table 187. MEA Precision Medical, by Application USD Million (2021-2026)
  • Table 188. MEA Precision Medical, by Technology USD Million (2021-2026)
  • Table 189. MEA Precision Medical, by End-use USD Million (2021-2026)
  • Table 190. Middle East Precision Medical, by Application USD Million (2021-2026)
  • Table 191. Middle East Precision Medical, by Technology USD Million (2021-2026)
  • Table 192. Middle East Precision Medical, by End-use USD Million (2021-2026)
  • Table 193. Africa Precision Medical, by Application USD Million (2021-2026)
  • Table 194. Africa Precision Medical, by Technology USD Million (2021-2026)
  • Table 195. Africa Precision Medical, by End-use USD Million (2021-2026)
  • Table 196. North America Precision Medical, by Country USD Million (2021-2026)
  • Table 197. North America Precision Medical, by Application USD Million (2021-2026)
  • Table 198. North America Precision Medical, by Technology USD Million (2021-2026)
  • Table 199. North America Precision Medical, by End-use USD Million (2021-2026)
  • Table 200. United States Precision Medical, by Application USD Million (2021-2026)
  • Table 201. United States Precision Medical, by Technology USD Million (2021-2026)
  • Table 202. United States Precision Medical, by End-use USD Million (2021-2026)
  • Table 203. Canada Precision Medical, by Application USD Million (2021-2026)
  • Table 204. Canada Precision Medical, by Technology USD Million (2021-2026)
  • Table 205. Canada Precision Medical, by End-use USD Million (2021-2026)
  • Table 206. Mexico Precision Medical, by Application USD Million (2021-2026)
  • Table 207. Mexico Precision Medical, by Technology USD Million (2021-2026)
  • Table 208. Mexico Precision Medical, by End-use USD Million (2021-2026)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Precision Medical: by Application USD Million (2015-2020)
  • Figure 5. Global Precision Medical: by Technology USD Million (2015-2020)
  • Figure 6. Global Precision Medical: by End-use USD Million (2015-2020)
  • Figure 7. South America Precision Medical Share (%), by Country
  • Figure 8. Asia Pacific Precision Medical Share (%), by Country
  • Figure 9. Europe Precision Medical Share (%), by Country
  • Figure 10. MEA Precision Medical Share (%), by Country
  • Figure 11. North America Precision Medical Share (%), by Country
  • Figure 12. Global Precision Medical share by Players 2020 (%)
  • Figure 13. Global Precision Medical share by Players (Top 3) 2020(%)
  • Figure 14. Global Precision Medical share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Medtronic PLC (Ireland) Revenue, Net Income and Gross profit
  • Figure 17. Medtronic PLC (Ireland) Revenue: by Geography 2020
  • Figure 18. Pfizer Inc., (United States) Revenue, Net Income and Gross profit
  • Figure 19. Pfizer Inc., (United States) Revenue: by Geography 2020
  • Figure 20. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 21. Novartis AG (Switzerland) Revenue: by Geography 2020
  • Figure 22. Qiagen (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Qiagen (Germany) Revenue: by Geography 2020
  • Figure 24. Teva Pharmaceuticals (Israel) Revenue, Net Income and Gross profit
  • Figure 25. Teva Pharmaceuticals (Israel) Revenue: by Geography 2020
  • Figure 26. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 27. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 28. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2020
  • Figure 30. Eli Lilly & Company (United States) Revenue, Net Income and Gross profit
  • Figure 31. Eli Lilly & Company (United States) Revenue: by Geography 2020
  • Figure 32. Global Precision Medical: by Application USD Million (2021-2026)
  • Figure 33. Global Precision Medical: by Technology USD Million (2021-2026)
  • Figure 34. Global Precision Medical: by End-use USD Million (2021-2026)
  • Figure 35. South America Precision Medical Share (%), by Country
  • Figure 36. Asia Pacific Precision Medical Share (%), by Country
  • Figure 37. Europe Precision Medical Share (%), by Country
  • Figure 38. MEA Precision Medical Share (%), by Country
  • Figure 39. North America Precision Medical Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Medtronic PLC (Ireland)
  • Pfizer Inc., (United States)
  • Novartis AG (Switzerland)
  • Qiagen (Germany)
  • Teva Pharmaceuticals (Israel)
  • Abbott Laboratories (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Eli Lilly & Company (United States)
Additional players considered in the study are as follows:
Quest Diagnostics Inc., (United States) , BioMérieux SA (France)
Select User Access Type

Key Highlights of Report


Feb 2022 249 Pages 58 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Rapid growth of genomic analysis " is seen as one of major growth factors of Precision Medical Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
United States will lead Precision Medical Market in coming years.

Know More About Global Precision Medical Report?